Investor relations

Investor relations

Second quarter and half year results 2014

Thursday, 31 July 2014

AstraZeneca will announce second quarter & half year results on Thursday, 31 July with a scheduled Stock Exchance release time of 07:00 BST (08:00 CEST, 02:00am EDT).

An analyst presentation of the results will take place at 12:00 BST (13:00 CEST, 07:00am EDT) and will be available to download from this page. Further details of this event are available below.

View details of the event

Latest downloads

American Society of Clinical Oncology

3 June 2014

American Thoracic Society AstraZeneca Analyst briefing

20 May 2014

AstraZeneca strategy update

6 May 2014

First quarter results 2014

24 April 2014

Annual Report 2013

AstraZeneca Annual Report 2013

Our Annual Report provides a wide range of information about our global business and how we are working, both within the company and in partnership with others, to push the boundaries of science and deliver medicines that transform the lives of people around the world.

Currency guidance 2014

In order to help analysts and investors estimate the impact of changing exchange rates on sales and earnings, the Company provides an annual 'currency sensitivity guide', alongside the rates upon which its earnings guidance is based.

The latest guide, intended to help estimate the impact of currency movements for 2014, is an update of the 2013 guidance given in January 2013.

View 2014 currency guidance

Keeping investors in touch

Download our iPad app now from the app store

AstraZeneca Investor Relations iPad app

The AstraZeneca Investor Relations iPad app provides instant access to our latest news, webcasts and presentations, events and leadership videos.

Notifications will keep you up to date with the most recent updates from AstraZeneca and synchronise to your device for reference.

Download and install from the iTunes store

Definition of Core Financial Measures

Definition of Core Financial Measures will change with effect from Q1 2013.

Read the announcement